Go to Article
Excerpt from www.sciencedaily.com
Researchers at University of California San Diego have found that the most common form of liver cancer — one with a high mortality rate — can be better targeted and treated using an innovative new stem cell-derived therapy, according to a recently published study in Cell Stem Cell.
The treatment, not yet studied in patients, involves the lab engineering of natural killer (NK) cells — white blood cells that destroy tumor cells — to more effectively battle hepatocellular carcinoma (HCC), one of the most treatment-resistant types of solid tumor.
Genetically modified NK-cell therapy doesn’t require personalization like chimeric antigen receptor (CAR)-expressing T-cell therapy — a relatively new, personalized form of immunotherapy. That means an NK-cell therapy could be mass produced and shelf-ready for patients, who could begin therapy without delay, their new research shows.
About The Author
.jpg%2F500px-Prime_Minister_Andy_Burnham_portrait_(cropped).jpg%3Futm_source%3Dcs.wikipedia.org%26utm_campaign%3Dparser%26utm_content%3Dthumbnail&f=1&nofb=1&ipt=3c71ed6002ac6e63648b6562a2aa39e7be3c5e2b0d5c8bd5146b59550735b0b4&ipo=images)
1 thought on “Stem cell-derived therapy shows promise against treatment-resistant liver cancer– www.sciencedaily.com”